Literature DB >> 21429962

The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function.

Simone Radavelli-Bagatini1, Amy R Blair, Joseph Proietto, Poli Mara Spritzer, Sofianos Andrikopoulos.   

Abstract

Infertility, associated with oligo/anovulation, increased ovarian volume, numerous follicular cysts, and metabolic disturbances such as obesity and insulin resistance (IR) are characteristics common to polycystic ovary syndrome (PCOS), the most common endocrine disorder in women of reproductive age. Here, we show that New Zealand obese (NZO) mice display similar metabolic characteristics such as obesity, leptin insensitivity, glucose intolerance, and IR. Importantly, NZO mice are poor breeders; however, the mechanism for this has not been investigated. The aim of this study was to assess the ovarian structure/morphology and sex hormone levels in female NZO and lean C57BL/6J control mice. Twenty-five NZO and twenty female control mice were studied at three different ages (young, adult, and aged). The animals were weighed, an insulin tolerance test was carried out, and blood was collected for measurement of hormone levels. The ovaries were removed for histological analysis. As expected, NZO mice presented higher body weights (P=0.001), increased basal plasma glucose (P=0.007), and insulin levels (P=0.001) as well as IR, compared with control mice. NZO mice showed an increased ovarian volume, reduced numbers of corpora lutea, and higher total follicle numbers (P=0.0001). The number of primordial follicles increased (P=0.02) at the young stage, as well as the amount of atretic follicles (P=0.03), in NZO compared with control mice. NZO mice also displayed reduced plasma LH and increased estradiol levels. In conclusion, NZO mice show a poor breeding performance due to decreased ovulation, increased number of primordial and atretic follicles, and ovarian size. Given that NZO mice are obese, hyperinsulinemic and insulin resistant, they are suitable for investigating pathophysiological mechanisms linking metabolic alterations with reproductive defects.

Entities:  

Mesh:

Year:  2011        PMID: 21429962     DOI: 10.1530/JOE-11-0022

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  11 in total

1.  Estradiol (E2) Improves Glucose-Stimulated Insulin Secretion and Stabilizes GDM Progression in a Prediabetic Mouse Model.

Authors:  Moritz Liebmann; Melissa Asuaje Pfeifer; Katharina Grupe; Stephan Scherneck
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

2.  Evaluation of a commercial multi-dimensional echocardiography technique for ventricular volumetry in small animals.

Authors:  Jana Grune; Annelie Blumrich; Sarah Brix; Sarah Jeuthe; Cathleen Drescher; Tilman Grune; Anna Foryst-Ludwig; Daniel Messroghli; Wolfgang M Kuebler; Christiane Ott; Ulrich Kintscher
Journal:  Cardiovasc Ultrasound       Date:  2018-07-03       Impact factor: 2.062

3.  Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats.

Authors:  Hua-Ling Zhai; Hui Wu; Hui Xu; Pan Weng; Fang-Zhen Xia; Yi Chen; Ying-Li Lu
Journal:  Reprod Biol Endocrinol       Date:  2012-01-25       Impact factor: 5.211

Review 4.  Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.

Authors:  Larissa Paixão; Ramon B Ramos; Anita Lavarda; Debora M Morsh; Poli Mara Spritzer
Journal:  Reprod Biol Endocrinol       Date:  2017-02-10       Impact factor: 5.211

5.  Tacrolimus in the prevention of adverse pregnancy outcomes and diabetes-associated embryopathies in obese and diabetic mice.

Authors:  Ahmad J H Albaghdadi; Melanie A Hewitt; Samantha M Putos; Michael Wells; Terence R S Ozolinš; Frederick W K Kan
Journal:  J Transl Med       Date:  2017-02-13       Impact factor: 5.531

6.  Low-Dose Tacrolimus Prevents Dysregulated Peri-Conceptional Ovarian and Systemic Immune Cellular Homeostasis in Subjects with PCOS.

Authors:  Ahmad J H Albaghdadi; Carolyn Ann Feeley; Frederick W K Kan
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

Review 7.  Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome.

Authors:  Isabel Huang-Doran; Stephen Franks
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-07       Impact factor: 5.555

8.  Alterations of polyunsaturated fatty acid metabolism in ovarian tissues of polycystic ovary syndrome rats.

Authors:  Rong Huang; Xinli Xue; Shengxian Li; Yuying Wang; Yun Sun; Wei Liu; Huiyong Yin; Tao Tao
Journal:  J Cell Mol Med       Date:  2018-03-30       Impact factor: 5.310

9.  Histological classification of canine ovarian cyst types with reference to medical history.

Authors:  Yvonne Knauf; Kernt Köhler; Sascha Knauf; Axel Wehrend
Journal:  J Vet Sci       Date:  2018-11-30       Impact factor: 1.672

10.  Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome.

Authors:  Nasim Behmanesh; Ali Abedelahi; Hojjatollah Nozad Charoudeh; Alireza Alihemmati
Journal:  Turk J Obstet Gynecol       Date:  2019-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.